A double-blind, randomized pilot study for comparison of Melissa officinalis L. and Lavandula angustifolia Mill. with Fluoxetine for the treatment of depression

Mostafa Araj-Khodaei, Ahmad Ali Noorbala, Reza Yarani, Fatemeh Emadi, Elham Emaratkar, Soghrat Faghihzadeh, Zahra Parsian, Fatemeh Alijaniha, Mohammad Kamalinejad, Mohsen Naseri, Mostafa Araj-Khodaei, Ahmad Ali Noorbala, Reza Yarani, Fatemeh Emadi, Elham Emaratkar, Soghrat Faghihzadeh, Zahra Parsian, Fatemeh Alijaniha, Mohammad Kamalinejad, Mohsen Naseri

Abstract

Background: Depression has rapidly progressed worldwide, and the need for an efficient treatment with low side effect has risen. Melissa officinalis L and Lavandula angustifolia Mill have been traditionally used in Asia for the treatment of depression. Many textbooks of traditional Persian medicine refer to these herbs for the treatment of depression while there are no adequate clinical trials to support this claim. The present study aimed to evaluate the efficacy of M. officinalis and L. angustifolia compared to fluoxetine for the treatment of mild to moderate depression in an 8-week randomized, double-blind clinical trial.

Methods: Forty-five adult outpatients who met the Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5) for major depression, were randomly assigned to 3 groups to daily receive either M. officinalis (2 g) or L. angustifolia (2 g) or fluoxetine (20 mg) and were assessed in weeks 0, 2, 4 and 8 by the Hamilton Rating Scale for Depression (HAM-D) including 17 items.

Results: Our study showed that M. officinalis and L. angustifolia effect similar to fluoxetine in mild to moderate depression. (F = 0.131, df = 2,42, p = 0.877).

Conclusion: Due to some restrictions in this study including absence of placebo group, large-scale trials are needed to investigate the anti-depressant effect of these two herbs with more details.

Trial registration: IRCT2014061718126N1 . Registration date: 2015-06-04-"Retrospectively registered".

Keywords: Depression; Fluoxetine; Herbal medicine; Lavandula angustifolia; Melissa officinalis; Traditional Persian medicine.

Conflict of interest statement

Dr. Mohsen Naseri, the author of this manuscript, is a member of the editorial board (Associate Editor) of this journal,

Figures

Fig. 1
Fig. 1
Flow diagram of study participation
Fig. 2
Fig. 2
Mean + − S.E.M. scores of Lavandula angustifolia (Group A), Flouxetine (Group B) and Melissa officinalis (Group C) on the Hamilton Depression Rating Scale. The horizontal symbol (**) was used to express statistical significance versus their respective baseline value and the symbol ns (no significance) were used for between-group comparisons

References

    1. Carey M, Small H, Yoong SL, Boyes A, Bisquera A, Sanson-Fisher R. Prevalence of comorbid depression and obesity in general practice: a cross-sectional survey. Br J Gen Pract. 2014;64(620):e122–e127.
    1. Üstün TB, Ayuso-Mateos JL, Chatterji S, Mathers C, Murray CJ. Global burden of depressive disorders in the year 2000. Br J Psychiatry. 2004;184(5):386–392.
    1. Gonzalez HM, Vega WA, Williams DR, Tarraf W, West BT, Neighbors HW. Depression care in the United States: too little for too few. Arch Gen Psychiatry. 2010;67(1):37–46.
    1. Kennedy SH. A review of antidepressant treatments today. Eur Neuropsychopharmacol. 2006;16(Supplement 5):S619–S623.
    1. Mozaffarpur SA, Naseri M, Esmaeilidooki MR, Kamalinejad M, Bijani A. The effect of cassia fistula emulsion on pediatric functional constipation in comparison with mineral oil: a randomized, clinical trial. DARU J Pharm Sci. 2012;20(1):83.
    1. Asghari M, Naseri M, Sabet Z, Davati A, Kamalinejad M, Jalali-Nadoushan MR, Shaali A, Doost S, Alamshekan M. Efficacy and safety of Ziabites (an Iranian traditional medicine compound) on glycemic control in type 2 diabetic patients. J Med Plants Res. 2013;7(22):1624–1627.
    1. Yarani R, Mansouri K, Mohammadi-Motlagh HR, Mahnam A, Emami Aleagha MS. In vitro inhibition of angiogenesis by hydroalcoholic extract of oak (Quercus infectoria) acorn shell via suppressing VEGF, MMP-2, and MMP-9 secretion. Pharm Biol. 2013;51(3):361–368.
    1. Yavari N, Emamian F, Yarani R, Reza Mohammadi-Motlagh H, Mansouri K, Mostafaie A. In vitro inhibition of angiogenesis by heat and low pH stable hydroalcoholic extract of Peganum harmala seeds via inhibition of cell proliferation and suppression of VEGF secretion. Pharm Biol. 2015;53(6):855–861.
    1. Sarris J, Kavanagh DJ, Byrne G. Adjuvant use of nutritional and herbal medicines with antidepressants, mood stabilizers and benzodiazepines. J Psychiatr Res. 2010;44(1):32–41.
    1. Akhondzadeh S, Fallah-Pour H, Afkham K, Jamshidi AH, Khalighi-Cigaroudi F. Comparison of Crocus sativus L. and imipramine in the treatment of mild to moderate depression: a pilot double-blind randomized trial [ISRCTN45683816] BMC Complement Altern Med. 2004;4:12.
    1. Naseri M, Mojab F, Khodadoost M, Kamalinejad M, Davati A, Choopani R, Hasheminejad A, Bararpoor Z, Shariatpanahi S, Emtiazy M. The study of anti-inflammatory activity of oil-based dill (Anethum graveolens L.) extract used topically in formalin-induced inflammation male rat paw. Iran J Pharm Res. 2012;11(4):1169–1174.
    1. Mokaberinejad R, Zafarghandi N, Bioos S, Dabaghian FH, Naseri M, Kamalinejad M, Amin G, Ghobadi A, Tansaz M, Akhbari A. Mentha longifolia syrup in secondary amenorrhea: a double-blind, placebo-controlled, randomized trials. DARU J Pharm Sci. 2012;20(1):97.
    1. Ghajar A, Neishabouri S, Velayati N, Jahangard L, Matinnia N, Haghighi M, Ghaleiha A, Afarideh M, Salimi S, Meysamie A. Crocus sativus L. versus Citalopram in the Treatment of Major Depressive Disorder with Anxious Distress: A Double-Blind, Controlled Clinical Trial. Pharmacopsychiatry. 2016;50(4):152–60.
    1. Soltanian AR, Mehdibarzi D, Faghihzadeh S, Naseri M, Gerami A. Mixture of Arnebia euchroma and Matricaria chamomilla (Marhame-Mafasel) for pain relief of osteoarthritis of the knee–a two-treatment, two-period crossover trial. Arch Med Sci. 2010;6(6):950.
    1. Rezaeizadeh H, AM, Naseri M, Shams Ardakani MR. The traditional Iranian medicine point of view on health and disease. Iran J Public Health. 2009;38(1):169–172.
    1. Naseri M, Ardakani MRS. The school of traditional Iranian medicine: the definition, origin and advantages. J Int Soc History Islamic Med. 2004;3:17–21.
    1. Naseri M, HN . Maintaining health in the view point of traditional Iranian medicine. Tehran: Institute for Traditional Iranian Medicine Publication; 2014.
    1. Ghafouri RR, Araj-khodaei M, Targhi ST, Varshochi M, Parsian Z, Yarani R, Golzari SE. First report of a disease by rhazes 10 centuries ago. Int J Prev Med. 2019;10(1):6.
    1. Khodaei MA, Ghaffari F, Emadi F, Emaratkar E, Alijaniha F, Noorbala AA, Naseri M. Healthy lifestyle in prevention and treatment of depression from the view of Iranian traditional medicine. Med History J. 2017;9(30):169–192.
    1. Taheri-Targhi S, Gjedde A, Araj-Khodaei M, Rikhtegar R, Parsian Z, Zarrintan S, Torbati M, Vafaee MS. Avicenna (980–1037 CE) and his Early Description and Classification of Dementia. J Alzheimers Dis. 2019;71(4):1093–8.
    1. Aghili Khorasani MH. Makhzan al Advieh. Tehran: Research institute for Islamic and Complementary Medicine, Iran University of Medical Sciences; 2001.
    1. Sina I. The canon of medicine. Sharafkandi A, trans,[in Persian]. Sorush, Tehran; 1997. p. 190–3.
    1. Hossaini-Tabib M. Tohfe of hakim Momen. Tehran and Qum: Mostafavi Press; 1959.
    1. Patwardhan B, Mashelkar RA. Traditional medicine-inspired approaches to drug discovery: can Ayurveda show the way forward? Drug Discov Today. 2009;14(15):804–811.
    1. Aghili M. Makhzan-al-Advia. Tehran: Tehran University of Medical Sciences; 2009. p. 328.
    1. Dioscorides P, Osbaldeston TA, Wood RP. Dioscorides de materia medica: being a herbal with many other medical materials written in Greek in the first century of the common era; a new indexed version in modern English. Johannesburg: Ibidis; 2000. p. 352–5.
    1. Scholey A, Gibbs A, Neale C, Perry N, Ossoukhova A, Bilog V, Kras M, Scholz C, Sass M, Buchwald-Werner S. Anti-stress effects of lemon balm-containing foods. Nutrients. 2014;6(11):4805–4821.
    1. Abuhamdah S, Chazot PL. Lemon balm and lavender herbal essential oils: old and new ways to treat emotional disorders? Curr Anaesthesia Crit Care. 2008;19(4):221–226.
    1. Alijaniha F, Naseri M, Afsharypuor S, Fallahi F, Noorbala A, Mosaddegh M, Faghihzadeh S, Sadrai S. Heart palpitation relief with Melissa officinalis leaf extract: double blind, randomized, placebo controlled trial of efficacy and safety. J Ethnopharmacol. 2015;164:378–384.
    1. Blumenthal M, Goldberg A, Brinckmann J. Herbal Medicine. Expanded Commission E monographs. Integr Med Commun. 2000.
    1. Ibn Sina AAH. The canon of medicine. Tehran: Soroush Press; 1997.
    1. López V, Martín S, Gómez-Serranillos MP, Carretero ME, Jäger AK, Calvo MI. Neuroprotective and neurological properties of Melissa officinalis. Neurochem Res. 2009;34(11):1955–1961.
    1. Emamghoreishi M, Talebianpour M. Antidepressant effect of Melissa officinalis in the forced swimming test. DARU J Pharm Sci. 2015;17(1):42–47.
    1. Allahverdiyev A, Duran N, Ozguven M, Koltas S. Antiviral activity of the volatile oils of Melissa officinalis L. against herpes simplex virus type-2. Phytomedicine. 2004;11(7–8):657–661.
    1. Butterweck V, Hegger M, Winterhoff H. Flavonoids of St. John’s Wort reduce HPA axis function in the rat. Planta Med. 2004;70(10):1008–1011.
    1. Ghazizadeh J, Hamedeyazdan S, Torbati M, Farajdokht F, Fakhari A, Mahmoudi J, Araj-khodaei M, Sadigh-Eteghad SJEP . Melissa officinalis L. hydro-alcoholic extract inhibits anxiety and depression through prevention of central oxidative stress and apoptosis. 2020.
    1. Scalzo R. Naturopathic handbook of herbal formulas a practical and concise herb User's guide. 1994.
    1. Buchbauer G, Jirovetz L, Jager W, Dietrich H, Plank C. Aromatherapy: evidence for sedative effects of the essential oil of lavender after inhalation. Z Naturforsch C. 1991;46(11–12):1067–1072.
    1. Itai T, Amayasu H, Kuribayashi M, Kawamura N, Okada M, Momose A, Tateyama T, Narumi K, Uematsu W, Kaneko S. Psychological effects of aromatherapy on chronic hemodialysis patients. Psychiatry Clin Neurosci. 2000;54(4):393–397.
    1. Akhondzadeh S, Kashani L, Fotouhi A, Jarvandi S, Mobaseri M, Moin M, Khani M, Jamshidi AH, Baghalian K, Taghizadeh M. Comparison of Lavandula angustifolia mill. Tincture and imipramine in the treatment of mild to moderate depression: a double-blind, randomized trial. Prog Neuro-Psychopharmacol Biol Psychiatry. 2003;27(1):123–127.
    1. Chen SL, Chen CH. Effects of lavender tea on fatigue, depression, and maternal-infant attachment in sleep-disturbed postnatal women. Worldviews Evid-Based Nurs. 2015;12(6):370–379.
    1. Marinova D, Ribarova F, Atanassova M. Total phenolics and total flavonoids in Bulgarian fruits and vegetables. J Univ Chem Technol Metallurgy. 2005;40(3):255–260.
    1. Beketov EV, Pakhomov VP, Nesterova OV. Improved method of flavonoid extraction from bird cherry fruits. Pharm Chem J. 2005;39(6):316–318.
    1. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, Rush AJ, Walters EE, Wang PS, National Comorbidity Survey R The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R) JAMA. 2003;289(23):3095–3105.
    1. Mendlewicz J. Optimising antidepressant use in clinical practice: towards criteria for antidepressant selection. Br J Psychiatry. 2001;179(42):s1–s3.
    1. O'Leary OF, Dinan TG, Cryan JF. Faster, better, stronger: towards new antidepressant therapeutic strategies. Eur J Pharmacol. 2015;753:32–50.
    1. Kasper S, Volz HP, Dienel A, Schlafke S. Efficacy of Silexan in mixed anxiety-depression--a randomized, placebo-controlled trial. Eur Neuropsychopharmacol. 2016;26(2):331–340.
    1. Taiwo AE, Leite FB, Lucena GM, Barros M, Silveira D, Silva MV, Ferreira VM. Anxiolytic and antidepressant-like effects of Melissa officinalis (lemon balm) extract in rats: influence of administration and gender. Indian J Pharmacol. 2012;44(2):189–192.
    1. Lin SH, Chou ML, Chen WC, Lai YS, Lu KH, Hao CW, Sheen LY. A medicinal herb, Melissa officinalis L ameliorates depressive-like behavior of rats in the forced swimming test via regulating the serotonergic neurotransmitter. J Ethnopharmacol. 2015;175:266–272.
    1. Solberg E. The effects of powdered fertilized eggs on depression. J Med Food. 2011;14(7–8):870–875.
    1. Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, Johnson BT. Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med. 2008;5(2):e45.
    1. Kirsch I. The Placebo Effect in the Treatment of Depression and Anxiety. Front Psychiatry. 2019;10:407.

Source: PubMed

3
Iratkozz fel